430 related articles for article (PubMed ID: 23474015)
1. Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans.
Jasinska AJ; Zorick T; Brody AL; Stein EA
Neuropharmacology; 2014 Sep; 84():111-22. PubMed ID: 23474015
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.
Wittenberg RE; Wolfman SL; De Biasi M; Dani JA
Neuropharmacology; 2020 Oct; 177():108256. PubMed ID: 32738308
[TBL] [Abstract][Full Text] [Related]
3. Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice.
Besson M; David V; Baudonnat M; Cazala P; Guilloux JP; Reperant C; Cloez-Tayarani I; Changeux JP; Gardier AM; Granon S
Psychopharmacology (Berl); 2012 Mar; 220(1):1-14. PubMed ID: 21901321
[TBL] [Abstract][Full Text] [Related]
4. Cognitive Effects of Nicotine: Recent Progress.
Valentine G; Sofuoglu M
Curr Neuropharmacol; 2018; 16(4):403-414. PubMed ID: 29110618
[TBL] [Abstract][Full Text] [Related]
5. Molecular and cellular mechanisms of action of nicotine in the CNS.
Barik J; Wonnacott S
Handb Exp Pharmacol; 2009; (192):173-207. PubMed ID: 19184650
[TBL] [Abstract][Full Text] [Related]
6. In vivo brain imaging of human exposure to nicotine and tobacco.
Sharma A; Brody AL
Handb Exp Pharmacol; 2009; (192):145-71. PubMed ID: 19184649
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence.
Fowler CD; Turner JR; Imad Damaj M
Handb Exp Pharmacol; 2020; 258():373-393. PubMed ID: 31267166
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-based medication development for the treatment of nicotine dependence.
Xi ZX; Spiller K; Gardner EL
Acta Pharmacol Sin; 2009 Jun; 30(6):723-39. PubMed ID: 19434058
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
Hamouda AK; Bautista MR; Akinola LS; Alkhlaif Y; Jackson A; Carper M; Toma WB; Garai S; Chen YC; Thakur GA; Fowler CD; Damaj MI
Neuropharmacology; 2021 Jun; 190():108568. PubMed ID: 33878302
[TBL] [Abstract][Full Text] [Related]
10. CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.
Sala M; Braida D; Pucci L; Manfredi I; Marks MJ; Wageman CR; Grady SR; Loi B; Fucile S; Fasoli F; Zoli M; Tasso B; Sparatore F; Clementi F; Gotti C
Br J Pharmacol; 2013 Feb; 168(4):835-49. PubMed ID: 22957729
[TBL] [Abstract][Full Text] [Related]
11. The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG.
Beaver JD; Long CJ; Cole DM; Durcan MJ; Bannon LC; Mishra RG; Matthews PM
Neuropsychopharmacology; 2011 Aug; 36(9):1792-800. PubMed ID: 21544072
[TBL] [Abstract][Full Text] [Related]
12. α4α6β2* nicotinic acetylcholine receptor activation on ventral tegmental area dopamine neurons is sufficient to stimulate a depolarizing conductance and enhance surface AMPA receptor function.
Engle SE; Shih PY; McIntosh JM; Drenan RM
Mol Pharmacol; 2013 Sep; 84(3):393-406. PubMed ID: 23788655
[TBL] [Abstract][Full Text] [Related]
13. Use of Electronic Cigarettes Leads to Significant Beta2-Nicotinic Acetylcholine Receptor Occupancy: Evidence From a PET Imaging Study.
Baldassarri SR; Hillmer AT; Anderson JM; Jatlow P; Nabulsi N; Labaree D; Cosgrove KP; O'Malley SS; Eissenberg T; Krishnan-Sarin S; Esterlis I
Nicotine Tob Res; 2018 Mar; 20(4):425-433. PubMed ID: 28460123
[TBL] [Abstract][Full Text] [Related]
14. In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
Jackson A; Bagdas D; Muldoon PP; Lichtman AH; Carroll FI; Greenwald M; Miles MF; Damaj MI
Neuropharmacology; 2017 May; 118():38-45. PubMed ID: 28279662
[TBL] [Abstract][Full Text] [Related]
15. Association of nicotine addiction and nicotine's actions with separate cingulate cortex functional circuits.
Hong LE; Gu H; Yang Y; Ross TJ; Salmeron BJ; Buchholz B; Thaker GK; Stein EA
Arch Gen Psychiatry; 2009 Apr; 66(4):431-41. PubMed ID: 19349313
[TBL] [Abstract][Full Text] [Related]
16. Nicotine self-medication of cognitive-attentional processing.
Evans DE; Drobes DJ
Addict Biol; 2009 Jan; 14(1):32-42. PubMed ID: 18855804
[TBL] [Abstract][Full Text] [Related]
17. The nicotinic cholinergic system function in the human brain.
Nees F
Neuropharmacology; 2015 Sep; 96(Pt B):289-301. PubMed ID: 25446570
[TBL] [Abstract][Full Text] [Related]
18. Altered amygdala function in nicotine addiction: insights from human neuroimaging studies.
Mihov Y; Hurlemann R
Neuropsychologia; 2012 Jul; 50(8):1719-29. PubMed ID: 22575084
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic receptors in non-human primates: Analysis of genetic and functional conservation with humans.
Shorey-Kendrick LE; Ford MM; Allen DC; Kuryatov A; Lindstrom J; Wilhelm L; Grant KA; Spindel ER
Neuropharmacology; 2015 Sep; 96(Pt B):263-73. PubMed ID: 25661700
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
